Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Nasal Drug Delivery Technology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Nasal Drug Delivery Technology Market By Dosage Form
1.2.2.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
1.2.2.2. Global Nasal Drug Delivery Technology Market Revenue Share By Dosage Form in 2017
1.2.2.3. Spray
1.2.2.4. Drops
1.2.2.5. Gel
1.2.2.6. Powder
1.2.2.7. Others
1.2.3. Nasal Drug Delivery Technology Market By Container Type
1.2.3.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Container Type (2015-2026)
1.2.3.2. Pressurized
1.2.3.3. Non-pressurized
1.2.3.4. Others
1.2.4. Nasal Drug Delivery Technology Market By Therapeutic Application
1.2.4.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison By Therapeutic Application (2015-2026)
1.2.4.2. Nasal Congestion
1.2.4.3. Rhinitis
1.2.4.4. Asthma
1.2.4.5. Others
1.2.5. Nasal Drug Delivery Technology Market by Geography
1.2.5.1. Global Nasal Drug Delivery Technology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Nasal Drug Delivery Technology Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nasal Drug Delivery Technology Major Manufacturers in 2017
CHAPTER 4. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY DOSAGE FORM
4.1. Global Nasal Drug Delivery Technology Revenue By Dosage Form
4.2. Spray
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Drops
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Gel
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Powder
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Other
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY CONTAINER TYPE
5.1. Global Nasal Drug Delivery Technology Revenue By Container Type
5.2. Pressurized
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Non-pressurized
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NASAL DRUG DELIVERY TECHNOLOGY MARKET BY THERAPEUTIC APPLICATION
6.1. Global Nasal Drug Delivery Technology Revenue By Therapeutic Application
6.2. Nasal Congestion
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Rhinitis
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Asthma
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
7.1. North America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Nasal Drug Delivery Technology Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
8.1. Europe Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
9.1. Asia-Pacific Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
10.1. Latin America Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
11.1. Middle East Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET BY COUNTRY
12.1. Africa Nasal Drug Delivery Technology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Nasal Drug Delivery Technology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Container Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Therapeutic Application, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. NAVEH Pharma Ltd.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. GlaxoSmithKline PLC
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. ENT Technologies Pty. Ltd.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. AstraZeneca PLC
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Douglas Pharmaceuticals Ltd.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Pfizer, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. PendoPharm, Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. OptiNose, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. B.F. Ascher & Company, Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Becton
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Dickinson and Company
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Cadila Pharmaceuticals Ltd.
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Promius Pharma, LLC.
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Type Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. Others
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Type Portfolio
13.14.5. Key Developments
13.14.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
